All data are based on the daily closing price as of September 18, 2025
p

PharmaResearch

214450.KQ
438.46 USD
-10.87
-2.42%

Overview

Last close
438.46 usd
Market cap
4.56B usd
52 week high
509.12 usd
52 week low
81.70 usd
Target price
566.11 usd

Valuation

P/E
N/A
Forward P/E
N/A
Price/Sales
14.0435
Price/Book Value
10.516
Enterprise Value
4.30B usd
EV/Revenue
13.2528
EV/EBITDA
32.9376

Key financials

Revenue TTM
324.38M usd
Gross Profit TTM
240.04M usd
EBITDA TTM
132.91M usd
Earnings per Share
N/A usd
Dividend
0.79 usd
Total assets
682.17M usd
Net debt
N/A usd

About

PharmaResearch Co., Ltd., together with its subsidiaries, operates as a biopharmaceutical company primarily in South Korea. The company offers Re-An eye drops for protecting eyes from corneal damages with various causes; JBP PLAMON injection, a brown ampoule containing a pale yellow transparent liquid; ZADAXIN injection, an adjunctive therapy for influenza vaccination in immunocompromised elderly patients; PLACENTEX injection for the treatment and tissue restoration of wounds; CLEVIEL VOLUME to temporarily improve facial wrinkles in adults through the physical restoration; Rejuran HB plus which is used for temporary improvement of adult's crow's feet wrinkles; Rejuvenex injection, a tissue regeneration activator that regenerates connective tissues, including ligament, tendon, skin, etc.; and Rejuvenex cream, which treats the wound through rapid tissue regeneration. It also provides REJURAN, a medical device for face (especially eye, perioral area), neck, Décolleté, hands, etc; CLEVIEL prime plus and contour plus with lidocaine medical devices; D+CELL 350 TRA I; and REJURAN moisturizer for daily skin protection, as well as REJUVENEX SCULPT V; REJURAN concentrate for sensitive and aged skin; REJURAN healing eye gel and mask; REJURAN sunscreen that protects skin from UV rays; and REJURAN recover soothing mask. In addition, the company offers D+CELL 350 TRA concentrated rejuvenation cream, intensive repair serum, activating facial toner, high potency eye lift, moisture balancer, mask, hair, cream, and hydro products; REJURAN tone-up booster; REJURAN FORTE; and CONJURAN medical devices. Further, it offers functional foods; and engages in the development of software and consulting businesses. The company was formerly known as Pharma Research Products Co., Ltd. and changed its name to PharmaResearch Co., Ltd. in April 2021. PharmaResearch Co., Ltd. was founded in 1993 and is headquartered in Gangneung-si, South Korea.
  • Symbol
    214450.KQ
  • Exchange
    KQ
  • Isin
    KR7214450009
  • Country
    South Korea
  • Sector
    Healthcare
  • Industry
    Biotechnology
  • CEO
    Mr. Sang-Soo Jung
  • Headquarter
    Gangneung-si
  • Web site
    https://pharmaresearch.co.kr
Jakota Newsletter

Stay ahead in the JAKOTA stock markets with our roundup of vital insights

Icon scroll to top